Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Le Vésinet, France.
Frequently asked questions
What sector does Novacyt S.A (NVYTF) operate in?
Novacyt S.A belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Novacyt S.A (NVYTF) current stock price?
As of the latest data, Novacyt S.A stock price is $0.57, with a previous close of $0.57.
What is Novacyt S.A (NVYTF) current market capitalization?
Novacyt S.A market cap is approximately 41.41 million.
What is Novacyt S.A (NVYTF) Earnings Per Share (EPS)?
The trailing EPS is -$0.42.
What is Novacyt S.A (NVYTF) EBITDA?
Novacyt S.A EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.84 million.
Does Novacyt S.A (NVYTF) pay dividends?
No. Novacyt S.A does not pay a dividend.
What is Novacyt S.A (NVYTF) beta (volatility) score?
Novacyt S.A has a beta of 1.039, meaning its volatility is roughly in line with the market.
